Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    5768289 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
Condition: Allergic Conjunctivitis
Intervention: Drug: beta-1,3-glucan

Study has passed its completion date and status has not been verified in more than two years.